Skip to main content
AUTOBIO DIAGNOSTICS CO., LTD logo

AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings

Ticker · 603658 ISIN · CNE100002GC4 LEI · 300300HTZSCUCA32U369 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,291 across all filing types
Latest filing 2018-12-17 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 603658

About AUTOBIO DIAGNOSTICS CO., LTD

https://en.autobio.com.cn/

Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.

Recent filings

Filing Released Lang Actions
第三届监事会第三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Zhengzhou Antu Biological Engineering Co., Ltd. It details the meeting date, attendance, and voting results on several proposals including capital increase, joint venture establishment, and construction project approval. The document is short (1032 characters) and primarily announces decisions made at a board meeting rather than providing detailed financial data or full reports. It does not contain financial statements or detailed management discussion. Therefore, it is best classified as a Board/Management Information (MANG) filing, which covers announcements of board decisions and management matters.
2018-12-17 Chinese
独立董事关于公司第三届董事会第三次会议相关事项的独立意见
Regulatory Filings
2018-12-17 Chinese
关于取得医疗器械注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of medical device registration certificates from a regulatory authority. It discusses product registration details, comparisons with similar products, potential impact on company performance, and risk warnings. There is no financial data, no mention of financial results, no shareholder voting, no management changes, no legal proceedings, no capital changes, and no report attachments. The document is a regulatory announcement about product certification, which does not fit into financial report categories like Annual Report, Interim Report, Earnings Release, or others. It is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other categories. The document length is short and it is not an announcement of a report publication, so RPA is not appropriate. Confidence is high due to clear regulatory announcement nature and absence of financial or governance content.
2018-12-12 Chinese
2018年第二次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality and compliance of the convening, holding, attendance, and voting procedures of the 2018 second extraordinary general meeting of shareholders of Zhengzhou Antu Bioengineering Co., Ltd. It details the voting results on various proposals related to the issuance of convertible bonds and other corporate matters. The document is not a report of financial results, audit, or management discussion, but rather a legal opinion on the shareholder meeting and its resolutions. This type of document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting outcomes of a shareholder meeting. The document length is sufficient and contains detailed voting results, not just an announcement of a report publication or a brief notice. Therefore, the correct classification is DVA with high confidence.
2018-12-05 Chinese
2018年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2018 second extraordinary general meeting of shareholders of Zhengzhou Antu Bioengineering Co., Ltd. It includes voting results for multiple proposals related to the issuance of convertible bonds, meeting attendance, and legal witness statements. The content is focused on the official voting results and decisions made at the shareholders' meeting rather than the full meeting materials or presentations. The document is not a full annual or interim report, nor is it a call transcript or management report. It is not a proxy solicitation or a remuneration report. The key focus is on the official voting outcomes of the shareholders' meeting. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (9502 characters) and detailed voting tables support this classification with high confidence.
2018-12-05 Chinese
使用闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a progress announcement regarding the company's use of idle raised funds for cash management, detailing amounts invested in various financial products and their returns as of specific dates. It is a regulatory announcement about financing activities related to the use of raised capital, not a full financial report or earnings release. The document length is short (1552 characters) and it provides specific updates on financing activities rather than comprehensive financial statements or management discussion. Therefore, it fits best under Capital/Financing Update (CAP).
2018-12-03 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.